4.5 Article

Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan

期刊

JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 323, 期 1-2, 页码 117-122

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2012.08.032

关键词

Multiple sclerosis; Neuromyelitis optica; Prevalence; Incidence; MRI; Epidemiology

资金

  1. Ministry of Health, Labor and Welfare of Japan
  2. National Hospital Organization of Japan
  3. Bayer Schering Pharma
  4. Biogen Idec
  5. Mitsubishi Tanabe Pharma Corporation
  6. Novartis Pharma
  7. GlaxoSmithKline
  8. Boehringer Ingelheim
  9. Genzyme
  10. Sanofi-Aventis
  11. Takeda Pharmaceutical Co. Ltd.
  12. Dainippon Sumitomo Pharma Co. Ltd.
  13. Otsuka Pharmaceutical Co. Ltd.
  14. Janssen Pharmaceutical Co. Ltd.
  15. Ono Pharmaceutical Co. Ltd.

向作者/读者索取更多资源

Objective: To carry out the third epidemiologic surveillance of multiple sclerosis (MS) in Tokachi province, on the northernmost island of Japan, and to compare the results of the present survey on the prevalence, incidence, and characteristics of MS and neuromyelitis optica (NMO) with those of previous surveys performed in 2001 and 2006. Methods: A data processing sheet was sent to all MS-related institutions in Tokachi province, and all sheets were collected in March 2011. The criteria of Poser were used for diagnosing MS and the criteria proposed by Wingerchuk for diagnosing NMO. We then compared the results of the present survey with those of previous surveys performed in 2001 and 2006 in the same community. Results: Fifty-seven patients diagnosed with MS according to the criteria of Poser were identified. The prevalence was 16.2/100,000 in 2011, which was higher than in the previous studies. The female/male ratio of MS was 2.63, 2.75, and 3.38 in 2001, 2006, and 2011, respectively. Three patients fulfilled the criteria for diagnosis of NMO in 2011; the prevalence of NMO was 0.9/100,000. Conclusions: The results of this study suggest that the prevalence and the female predominance of MS have been increasing, due to an increase in the incidence after 1990, and that the prevalence of NMO is relatively low in northern Japan. (C) 2012 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据